Cécile Gouttefangeas

16PUBLICATIONS
79CO-AUTHORS
Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 07, 2026
Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8+ T cells.

|Oct 09, 2025
Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking case.

Ana Maia, Juliane Schuhmacher, Silvio Nadalin

|May 07, 2025
Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II Trial.

Sara Fresnillo Saló, Juliane Schuhmacher, Anne Rahbech

|Apr 15, 2025
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development.

Steffen Lemke, Marissa L Dubbelaar, Patrick Zimmermann

|Mar 06, 2025
Author Correction: Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.

Lisa Bertrand, Annika Nelde, Bertha Cecilia Ramirez

|Feb 20, 2025
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.

Alice Talpin, Ana Maia, Jean-Marie Carpier

Pageof 3

Frequent Collaborators

7 joint publications

Hans-Georg Rammensee

5 joint publications

Annika Nelde

4 joint publications

Anna Schöllhorn

3 joint publications

Juliane Schuhmacher